Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

90 trials

NCT07885319
Recruiting
Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma
Phase 1/2 · China · 3 sites
Registry update: 2 Nov 2026
NCT07713732
Recruiting
TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
Phase 1 · Australia · 3 sites
Registry update: 1 Oct 2026
NCT07705334
Recruiting
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Phase 1 · United States · 3 sites
Registry update: 22 Oct 2026
2024-519812-15-00
Recruiting
ETCABio - Evaluation of Skin Tests in Biotherapy Allergies
Phase 4 · France · 1 site
Registry update: 19 Mar 2026
NCT06971848
Recruiting
Evaluation of Skin Tests in Biotherapy Allergies
Not applicable · France · 1 site
Registry update: 18 Jun 2026
NCT07192900
Recruiting
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · United States · 1 site
Registry update: 4 Aug 2026
NCT07443020
Recruiting
Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
Phase 1 · United States · 1 site
Registry update: 7 Apr 2026
2024-519626-21-00
Recruiting
IMMUNOPEC: Combination of neo-adjuvant Checkpoint Inhibition and Dendritic Cell Therapy (MesoPher) with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with Peritoneal Mesothelioma
Phase 2 · Netherlands · 1 site
Registry update: 16 Apr 2026
NCT07532902
Recruiting
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Phase 1 · United States · 7 sites
Registry update: 16 Sept 2026
NCT07234058
Recruiting
Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
Phase 2 · France · 37 sites
Registry update: 11 Aug 2026
2024-519208-29-00
Recruiting
Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma
Phase 2 · France · 37 sites
Registry update: 6 Nov 2025
NCT07563738
Recruiting
A 2-part Phase 1/2 Open-label Trial on ODM-212
Phase 1/2 · Switzerland, Denmark, Spain, Finland, France, United Kingdom, United States · 23 sites
Registry update: 5 Nov 2026
NCT06907095
Recruiting
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
Not applicable · France · 1 site
Registry update: 30 Mar 2026
NCT07277413
Recruiting
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · United States · 23 sites
Registry update: 28 Sept 2026
NCT07510815
Recruiting
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/2 · China · 1 site
Registry update: 6 Apr 2026
NCT07126509
Recruiting
Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
Not applicable · United States · 1 site
Registry update: 17 Feb 2026
NCT07330271
Recruiting
PTC-Guided Therapy for Peritoneal Mesothelioma
Not applicable · China · 1 site
Registry update: 15 Jun 2026
NCT06503146
Recruiting
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · United States · 1 site
Registry update: 29 Oct 2026
NCT06996249
Recruiting
Prospective Data Collection Initiative on Thoracic Malignancies
Not applicable · Netherlands · 23 sites
Registry update: 7 Jul 2026
NCT07121374
Recruiting
NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
Phase 1/2 · Belgium · 2 sites
Registry update: 13 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.